Intrinsic Value of S&P & Nasdaq Contact Us

Bionano Genomics, Inc. BNGO NASDAQ

NASDAQ Capital Marke • Healthcare • Medical - Diagnostics & Research • US • USD

SharesGrow Score
47/100
3/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$46.50
+3743%

Stock Statistics — BNGO

Bionano Genomics, Inc. (BNGO) has a market capitalization of $3.97M and trades at $1.21. The 52-week range is 1.06-5.5.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0.2, Earnings Per Share (EPS) of $-4.85, annual revenue of $28.51M.

The stock has a beta of 1.60, operates in the Healthcare sector.

Trading Data
Current Price$1.21
52-Week Range1.06-5.5
Volume209.04K
Avg Volume (30D)353.88K
Market Cap$3.97M
Beta (1Y)1.60
Company
IPO Date2018-08-21
Employees98
CEORobert Erik Holmlin
CountryUS
ExchangeNASDAQ Capital Marke
CurrencyUSD
ISINUS09075F4046
CUSIP09075F404
Income (Latest Year)
Revenue$28.51M
Gross Profit$6.26M
EBITDA$-23.61M
Operating Income$-33.34M
Net Income$-26.4M
EPS$-4.85
EPS Diluted$-4.85
Shares Outstanding$5.45M
Balance Sheet (Latest Year)
Total Assets$73.58M
Current Assets$45.39M
Cash & ST Investments$13.26M
Total Liabilities$29.16M
Total Debt$6.92M
Net Debt$3.93M
Total Equity$44.42M
Debt / Equity0.16
Valuation Ratios
P/E Ratio-0.2
P/S Ratio0.14
P/B Ratio0.09
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message